nerve agent antidotes and pretreatment drug interactions

File: 970815_may96_decls7_0001.txt
Page: 0001
Total Pages: 2
Subject = nerve agent antidotes and pretreatment drug interactions        

Parent Organization = XVIII CORPS 

Unit = 24TH ID     

Folder Title = INCOMING MSG  -  DESERT SHIELD  CHEM                                                            

Document Number =          4

Box ID = BX001424










            PRIORITY

                                    PT 00454         255/1414Z                                   PAGE 01


            ACTION:                                                                            xx    D ()I m  TCC     xx
                                                                                               xx                     xx
            PRIMARY INFO:                                                                      xx  ROUTER(           )XX
                                                                                               xx                     xx
            COPIES FOP,                                                                        xx  supv              )XX
                                                                                               xx        9 xx
            soot            Cfo)P REA     L/E t                                 ADVCYT         X)( FITED(            )xx
            vi;Tuz,EO6 RHCGAAAI;0501F,/ 2550638-UUUU--RUCLRPA.
            znit tiuuuu     ccsgo8@? 2.5514n5
               IfIS302 SEP (O a
               M CINCF()P FT MCrfICIISOIJ rA//PCMI)-:PM//O
               0 A Tr, 9ft 79
            AT(i 91&9
            RUEOHNA/CDR       441HMED[iDE FT tiRAGG NC//AFZA-)(A//
            RUCLBFA/COR       ISTMEOGP FT HOOD TX//AFVG-MG//
            RUWMFOA/CnR       62D MED GP FT LFWIS WA//AFZH-MG//
            RUWTHt4A/COR      930 EVAC HOSP FT LEOATARDWOOD MO//AFFU-EV//
            RUEE)GEA/CDR      46TH CSfi FT f)EvENS MA//AFZD-CSH//
            RUEOAGA/CDR       FTSTH EVAC HOSP FT LEE VA//AFFL-HS//
            INFO RHIVHBA/CDR24THINFOrv DHAHRAN SA//DIV-SURG//p,-'-
            RHIVF&A/CDRXVIIIABNCORPS FwD//AFZA-MD//
            RUFLEIYX/S2CA8NDlV 'FWD//AFVC-Mn//

            RUDCACA/IITH ADA BOE FwD//SURG//
            RUEBSAA/ARCENT FWD//AFRO-MD//
            P 080:>.307 SEP QO
            FM DA WASHINGTON DC//DAMO-000-AOC//
            70 RHCGSRR/CINCFOR FT MCPHERSON GAIIFCMDII
            RUFOAAA/CDR 7TH MEDCOM HEI[)ELSERG GE//AEMPE-PS//
            RUwTNFH/CDRUSAHSC FT SA14 HOUSTON TX
            RUCOLEA/CDRARCENT MAIN RIYADH SA//AFRD-t4O/@
            RHCGSRR/CDRARCENI FT MCPHEKSON GA//AFR07MD//
            RUE-OHNA/CDRIBTH ARN CORPS FT'fiRAGG NC/./AFZf4z-f4D//
               NFO R(JEADWD/OA WASHINGTON DC//DASG-HCO/OASG-PSP//-.
               T
               NCLAS




            SuBirCT:        kEPV,E--AGENT- AVTT-DO-TE'
                            ADVERSE EFFECTSI@
            1.    RECENT INGUIRIES TO THE ARMY SURGEON GENERAL*S OFFICE HAVE
            INDICATED       THE NEED FOR DISSEMINATION OF ADDITIONAL GUIDANCE                        AND
            INFORMATION ON NERVE AGENT ANTIDOTES AND PRETREATMENTS.
            SPECI;'TCJtLLY# CONCFRNS HAVE BEEN RAISED AS TO WHETHER SOLDIERS ON$
            MEDICATIDh'S FOR EXISTING mEurCAL DROBLEMS (SUCH AS HYPERTENSION



            PPIORITY